News Headlines
-
Castor Collaborates With Microsoft To Bring Practical AI To Clinical Trials
3/12/2024
In February 2024, Castor announced its collaboration with Microsoft to use Microsoft Azure to bring modern artificial intelligence (AI) to clinical trials.
- Signant Health Unveils Next-Level Advancements In Efficient, Compliant IP Management With Updates To Its Clinical Supply Solutions 3/7/2024
-
Join Us At Life Sciences Connect 2024!
2/26/2024
Join us and our global community of customer advocates and industry leaders at Oracle Life Sciences Connect 2024 for an in-depth discussion of today’s life sciences environment. Next up is Boston in March 2024.
-
PCM Trials Acquires EmVenio Research
2/13/2024
PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials (DCTs), today announced the acquisition of EmVenio Research based in Durham, North Carolina.
-
Crucial Data Solutions And nmible Join Forces To Provide A Solution For Seamless Participant Reimbursement In Clinical Trials
2/12/2024
Crucial Data Solutions (CDS), the only SaaS platform to empower customer-driven global clinical trials for web and mobile environments, and nmible, a provider of cost effective clinical trial payment solutions, announced today they have formed a strategic partnership.
-
Crucial Data Solutions Recognized As A Major Contender In Everest Group’s Decentralized Clinical Trial Platforms PEAK Matrix® Assessment 2023
2/12/2024
Crucial Data Solutions (CDS), the only SaaS platform provider to empower customer-driven global clinical trials for web and mobile environments, announced today they have been recognized as a Major Contender in Everest Group’s Decentralized Clinical Trial Platforms PEAK Matrix® for the second year in a row.
-
Novo Holdings To Acquire CDMO Catalent Pharma Solutions For $16.5 Billion
2/5/2024
Catalent, Inc. (NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, today announced that they have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis.
-
Greenphire Announces Acquisition Of Clincierge To Enhance Clinical Trial Support Services
2/1/2024
Greenphire, a leading innovator in software solutions for streamlining clinical trials, proudly announces the acquisition of Clincierge, a premier provider of concierge travel and logistics support for patients participating in clinical trials.
- C-Path, ActiGraph, And University Of Canberra Collaborate To Generate Evidence To Support Regulatory Qualification Of Novel Digital Health Technology Measures In Chronic Heart Failure 2/1/2024
-
J.P. Morgan Week 2024: News, Trends, And Highlights
1/26/2024
With JPM officially over, uncover what top leaders and innovators across pharma said about the "big bets" for this year and beyond.